Zhengye Biotechnology Holding Limited (ZYBT)
Zhengye Biotechnology Holding will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $5.00
Shares Offered
1,500,000
Deal Size
$6.75M

Company Description

Zhengye Biotechnology Holding, through its operating entity, focus on the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock.

For nearly 20 years, the operating entity has been committed to enhancing the health of livestock by offering a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs.

The operating entity’s products are available in 29 provincial regions across China and are exported overseas, to Vietnam, Pakistan, and Egypt.

Zhengye Biotechnology Holding Limited
Country China
Founded 2004
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 299
CEO Songlin Song

Contact Details

Address:
No.1 Lianmeng Road, Jilin Economic & Technical Development Zone
Jilin City, Jilin Province
China
Phone +86-0432-63047008
Website jlzybio.com

Stock Details

Ticker Symbol ZYBT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency CNY
CIK Code 0001975641
SIC Code 2834

Key Executives

Name Position
Zhenfa Han Director and Chairman of the Board
Songlin Song Chief Executive Officer
Wenhua Sun Director
Ping Wang Chief Financial Officer
Zhongyao Liu Vice General Manager
Wei Lian Vice General Manager
Yawen Dong Vice General Manager
Yuyou He Vice General Manager
Wanlin Zhang Vice General Manager
Yuhong Cheng Vice General Manager

Latest SEC Filings

Date Type Title
Nov 21, 2024 FWP Free Writing Prospectus
Nov 15, 2024 POS AM Post-Effective amendments for registration statement
Sep 30, 2024 EFFECT Notice of Effectiveness
Sep 18, 2024 F-1/A [Amend] Registration statement for certain foreign private issuers
Aug 27, 2024 FWP Free Writing Prospectus
Aug 22, 2024 F-1/A [Amend] Registration statement for certain foreign private issuers
Jun 27, 2024 FWP Free Writing Prospectus
Jun 21, 2024 FWP Free Writing Prospectus
Jun 14, 2024 F-1/A [Amend] Registration statement for certain foreign private issuers
Jun 4, 2024 UPLOAD Filing